151 related articles for article (PubMed ID: 7920160)
41. Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response.
Neves S; Faneca H; Bertin S; Konopka K; Düzgüneş N; Pierrefite-Carle V; Simões S; Pedroso de Lima MC
Cancer Gene Ther; 2009 Jan; 16(1):91-101. PubMed ID: 18690206
[TBL] [Abstract][Full Text] [Related]
42. [Antisense gene therapy of respiratory syncytial virus infection].
Cui YX; Yang XQ
Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):629-32. PubMed ID: 17083798
[No Abstract] [Full Text] [Related]
43. Suicide Gene Therapy for Oral Squamous Cell Carcinoma.
Faneca H; Düzgüneş N; Pedroso de Lima MC
Methods Mol Biol; 2019; 1895():43-55. PubMed ID: 30539528
[TBL] [Abstract][Full Text] [Related]
44. Expression of long noncoding RNA-HOX transcript antisense intergenic RNA in oral squamous cell carcinoma and effect on cell growth.
Wu J; Xie H
Tumour Biol; 2015 Nov; 36(11):8573-8. PubMed ID: 26036760
[TBL] [Abstract][Full Text] [Related]
45. Oncogenes, tumor suppressors and viruses in oral squamous carcinoma.
Scully C
J Oral Pathol Med; 1993 Sep; 22(8):337-47. PubMed ID: 8283399
[TBL] [Abstract][Full Text] [Related]
46. Molecular therapy in ocular wound healing.
Cordeiro MF; Schultz GS; Ali RR; Bhattacharya SS; Khaw PT
Br J Ophthalmol; 1999 Nov; 83(11):1219-24. PubMed ID: 10535844
[No Abstract] [Full Text] [Related]
47. MicroRNA-based therapeutics for cancer.
Wang V; Wu W
BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
[TBL] [Abstract][Full Text] [Related]
48. Intracellular expression and function of antisense catalytic RNAs.
Castanotto D; Scherr M; Rossi JJ
Methods Enzymol; 2000; 313():401-20. PubMed ID: 10595369
[No Abstract] [Full Text] [Related]
49. Safety of in vivo adenovirus-mediated thymidine kinase treatment of oral cancer.
Sewell DA; Li D; Duan L; Westra WH; O'Malley BW
Arch Otolaryngol Head Neck Surg; 1997 Dec; 123(12):1298-302. PubMed ID: 9413357
[TBL] [Abstract][Full Text] [Related]
50. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.
Chen WH; Lecaros RL; Tseng YC; Huang L; Hsu YC
Cancer Lett; 2015 Apr; 359(1):65-74. PubMed ID: 25596376
[TBL] [Abstract][Full Text] [Related]
51. Gene therapy for HIV.
Lever AM
Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684
[No Abstract] [Full Text] [Related]
52. Gene therapy for oral cancer: efficient delivery of a 'suicide gene' to murine oral cancer cells in physiological milieu.
Young M; Overlid N; Konopka K; Düzgünes N
J Calif Dent Assoc; 2005 Dec; 33(12):967-71. PubMed ID: 16454240
[TBL] [Abstract][Full Text] [Related]
53. Progress towards gene therapy for HIV infection.
Yu M; Poeschla E; Wong-Staal F
Gene Ther; 1994 Jan; 1(1):13-26. PubMed ID: 7584055
[TBL] [Abstract][Full Text] [Related]
54. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
Sakata K
J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy in the management of oral cancer: a review of recent developments.
Ladeinde AL; Ogunlewe MO; Adeyemo WL; Bamgbose BO
Niger Postgrad Med J; 2005 Mar; 12(1):18-22. PubMed ID: 15827591
[TBL] [Abstract][Full Text] [Related]
56. Ex vivo and in vivo IGF-I antisense RNA strategies for treatment of cancer in humans.
Anthony DD; Pan YX; Wu SG; Shen F; Guo YJ
Adv Exp Med Biol; 1998; 451():27-34. PubMed ID: 10026846
[No Abstract] [Full Text] [Related]
57. Colocalization of antisense RNAs and ribozymes with their target mRNAs.
Arndt GM; Rank GH
Genome; 1997 Dec; 40(6):785-97. PubMed ID: 9449790
[TBL] [Abstract][Full Text] [Related]
58. Indian gene therapy for oral cancer.
Sharma DC
Lancet Oncol; 2000 Nov; 1():131. PubMed ID: 11905646
[No Abstract] [Full Text] [Related]
59. Construction and expression of oligonucleotide-based antisense cassettes.
Amarzguioui M
Cold Spring Harb Protoc; 2011 Feb; 2011(2):pdb.prot5561. PubMed ID: 21285261
[No Abstract] [Full Text] [Related]
60. A possible advance in arterial gene therapy for aortic complications in the Marfan syndrome by local transfer of an antisense Mg-dependent hammerhead ribozyme.
Durlach J
Magnes Res; 2001 Mar; 14(1-2):65-7. PubMed ID: 11300623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
